Redefining What’s Possible Through Gastroenterology Research l Sanofi
Despite a multitude of currently available treatment options in IBD, many patients fail to respond to therapies or…
Press Release: Sanofi and Teva’s duvakitug phase 2b maintenance data demonstrated clinically meaningful durable efficacy in ulcerative colitis and Crohn’s disease
Sanofi Winthrop Industrie Sanofi and Teva’s duvakitug phase 2b maintenance data demonstrated clinically meaningful durable efficacy in ulcerative…